Cargando…

Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants

BACKGROUND: We elucidated the safety of treatment with alteplase at 0.6 mg/kg within 24 hours for patients on direct oral anticoagulants (DOACs) before ischemic stroke onset. METHODS AND RESULTS: Consecutive patients with acute ischemic stroke who underwent intravenous thrombolysis using alteplase a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okada, Takashi, Yoshimoto, Takeshi, Wada, Shinichi, Yoshimura, Sohei, Chiba, Tetsuya, Egashira, Shuhei, Kimura, Shunsuke, Shiozawa, Masayuki, Inoue, Manabu, Ihara, Masafumi, Toyoda, Kazunori, Takashima, Hiroshi, Koga, Masatoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673692/ https://www.ncbi.nlm.nih.gov/pubmed/36129032 http://dx.doi.org/10.1161/JAHA.122.025809

Ejemplares similares

Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial
por: Koga, Masatoshi, et al.
Publicado: (2020)

Intravenous Alteplase at 0.6 mg/kg for Unknown Onset Stroke with Prior Antithrombotic Medication: THAWS Randomized Clinical Trial
por: Koga, Masatoshi, et al.
Publicado: (2023)

THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial
por: Koga, Masatoshi, et al.
Publicado: (2014)

Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with End-Stage Renal Disease on Hemodialysis: A Narrative Review
por: Egashira, Shuhei, et al.
Publicado: (2022)

Evaluation of Workflow Delays in Stroke Reperfusion Therapy: A Comparison between the Year-Long Pre-COVID-19 Period and the with-COVID-19 Period
por: Yoshimoto, Takeshi, et al.
Publicado: (2022)

Outcome Prediction in Acute Stroke Patients by Continuous Glucose Monitoring
por: Wada, Shinichi, et al.
Publicado: (2018)

Identifying large ischemic core volume ranges in acute stroke that can benefit from mechanical thrombectomy
por: Yoshimoto, Takeshi, et al.
Publicado: (2021)

Impact of Renal Impairment on Intensive Blood-Pressure–Lowering Therapy and Outcomes in Intracerebral Hemorrhage: Results From ATACH-2
por: Fukuda-Doi, Mayumi, et al.
Publicado: (2021)

Blind Exchange With Mini-Pinning Technique Using the Tron Stent Retriever for Middle Cerebral Artery M2 Occlusion Thrombectomy in Acute Ischemic Stroke
por: Yoshimoto, Takeshi, et al.
Publicado: (2021)

Current status and future aspects in the Japan Stroke Data Bank
por: Wada, Shinichi, et al.
Publicado: (2023)

Consensus Guides on Stroke Thrombolysis for Anticoagulated Patients from Japan: Application to Other Populations
por: Toyoda, Kazunori, et al.
Publicado: (2018)

Effect of Heart Rate Variabilities on Outcome After Acute Intracerebral Hemorrhage: A Post Hoc Analysis of ATACH‐2
por: Miwa, Kaori, et al.
Publicado: (2021)

Tmax Mismatch Ratio to Identify Intracranial Atherosclerotic Stenosis‐Related Large‐Vessel Occlusion Before Endovascular Therapy
por: Yoshimoto, Takeshi, et al.
Publicado: (2023)

Left Ventricular Abnormality and Covert Atrial Fibrillation in Embolic Stroke of Undetermined Source
por: Ikenouchi, Hajime, et al.
Publicado: (2022)

Uric acid enhances alteplase-mediated thrombolysis as an antioxidant
por: Kikuchi, Kiyoshi, et al.
Publicado: (2018)

Intravenous thrombolysis with alteplase in the treatment of acute cerebral infarction
por: Gao, Lilin, et al.
Publicado: (2022)

Stability of alteplase for ultrasound-facilitated catheter-directed thrombolysis
por: Fanikos, John, et al.
Publicado: (2021)

Alteplase or tenecteplase for thrombolysis in ischemic stroke: An illustrated review
por: Zhu, Annie, et al.
Publicado: (2022)

Internal Carotid Artery Tortuosity: Impact on Mechanical Thrombectomy
por: Koge, Junpei, et al.
Publicado: (2022)

Intravenous nicardipine for Japanese patients with acute intracerebral hemorrhage: an individual participant data analysis
por: Toyoda, Kazunori, et al.
Publicado: (2022)

Practical “1-2-3-4-Day” Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study
por: Kimura, Shunsuke, et al.
Publicado: (2022)

Silver Jubilee of Stroke Thrombolysis With Alteplase: Evolution of the Therapeutic Window
por: Pan, Yuanmei, et al.
Publicado: (2021)

Effect of Apixaban Pretreatment on Alteplase-Induced Thrombolysis: An In Vitro Study
por: Thalerová, Sandra, et al.
Publicado: (2021)

Intravenous thrombolysis for acute ischemic stroke: From alteplase to tenecteplase
por: Yang, Nan, et al.
Publicado: (2023)

A Retrospective Study of thrombolysis with 0.6 mg/kg Recombinant Tissue Plasminogen Activator (rt-PA) in Mild Stroke
por: Yang, Jie, et al.
Publicado: (2016)

Use of Diffusion‐Weighted Imaging‐Alberta Stroke Program Early Computed Tomography Score (DWI‐ASPECTS) and Ischemic Core Volume to Determine the Malignant Profile in Acute Stroke
por: Yoshimoto, Takeshi, et al.
Publicado: (2019)

Risk Factors for Early Intracerebral Hemorrhage after Intravenous Thrombolysis with Alteplase
por: Lin, Xianda, et al.
Publicado: (2020)

Rivaroxaban concentrations in acute stroke patients with different dosage forms
por: Wada, Shinichi, et al.
Publicado: (2019)

Mechanical Thrombectomy Up to 24 Hours in Large Vessel Occlusions and Infarct Velocity Assessment
por: Inoue, Manabu, et al.
Publicado: (2021)

Edaravone, a Synthetic Free Radical Scavenger, Enhances Alteplase-Mediated Thrombolysis
por: Kikuchi, Kiyoshi, et al.
Publicado: (2017)

Using alteplase nephrostomy tube installation for thrombolysis of ureter tract clot obstruction
por: Lin, Paoyan, et al.
Publicado: (2021)

Effect of Alteplase Thrombolysis on Coagulation Function and Nerve Function of Patients with Ischemic Stroke
por: Zhao, Hong-Ying, et al.
Publicado: (2022)

Atherosclerotic Components in Thrombi Retrieved by Thrombectomy for Internal Carotid Artery Occlusion Due to Large Artery Atherosclerosis: A Case Report
por: Eto, Futoshi, et al.
Publicado: (2021)

Early changes in fibrinogen after administration of alteplase are associated with the short-term efficacy of thrombolysis
por: Lu, Tao, et al.
Publicado: (2018)

Determinants of 1-Year Unfavorable Outcomes of Intravenous Alteplase Thrombolysis for Acute Ischemic Stroke
por: Zhai, Mingfeng, et al.
Publicado: (2023)

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
por: Emberson, Jonathan, et al.
Publicado: (2014)

Small but Steady Steps in Stroke Medicine in Japan
por: Toyoda, Kazunori, et al.
Publicado: (2019)

Efficacy and safety of short-term high dosage dual antiplatelet therapy after 0.6 mg/kg rt-PA intravenous thrombolysis for acute ischemic stroke
por: Chen, Jing, et al.
Publicado: (2023)

A Comparative Study of Hemorrhagic Conversion Patterns After Stroke Thrombolysis With Alteplase Versus Tenecteplase
por: Ezzeldin, Mohamad, et al.
Publicado: (2023)

RNF213 p.R4810K (c.14429G > A) Variant Determines Anatomical Variations of the Circle of Willis in Cerebrovascular Disease
por: Eto, Futoshi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sg7vgrlic2unh1lq8u3r7rthfi